Hearing · house
Maintaining America’s Leadership in Biomedical Innovation: FDA’s Role in Advancing U.S. Drug Development.
2026-07-15 · 14:15
Source status: Scheduled
Committee
Location
2123, Rayburn House Office Building
Video
Witnesses
Dr. Cynthia Verst
President, Design and Delivery Innovation, R&D Solutions, IQVIA
Ms. Susan Winckler
CEO, Reagan-Udall Foundation for the FDA
Dr. Aaron Kowalski
CEO, Breakthrough T1D
Dr. Thomas Hwang
Assistant Professor of Medicine, Brigham and Women's Hospital and Harvard Medical School
Mr. Thomas Bollyky
Bloomberg Chair in Global Health, Senior Fellow for International Economics, Law, and Development; and Director of the Global Health Program, Council
Documents
Witness documents
- Witness Biography · PDF
- Witness Truth in Testimony · PDF
- Witness Statement · PDF
- Witness Biography · PDF
- Witness Truth in Testimony · PDF
- Witness Statement · PDF
- Witness Support Document · PDF
- Witness Support Document · PDF
- Witness Biography · PDF
- Witness Truth in Testimony · PDF
- Witness Statement · PDF
- Witness Support Document · PDF
- Witness Biography · PDF
- Witness Support Document · PDF
- Witness Truth in Testimony · PDF
- Witness Statement · PDF
- Witness Biography · PDF
- Witness Statement · PDF
- Witness Truth in Testimony · PDF
- Witness Statement · PDF
Hearing record
Committee activity
- Documents for the Record · Support Document · PDF
- Statement by the Honorable Brett Guthrie · Member Statements · PDF
- Statement by the Honorable H. Morgan Griffith · Member Statements · PDF
- Majority Staff Attendance · Support Document · PDF
- Statement by the Honorable Diana DeGette · Member Statements · PDF
- Statement by the Honorable Frank Pallone, Jr. · Member Statements · PDF
- Minority Staff Attendance · Support Document · PDF
Source: https://api.congress.gov/v3/committee-meeting/119/house/119457